- Report
- July 2024
- 200 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- July 2024
- 200 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- May 2024
- 160 Pages
Global
From €4362EUR$4,969USD£3,795GBP
- Report
- April 2023
- 160 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- January 2025
- 144 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- January 2025
- 145 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- December 2024
- 145 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- May 2024
- 124 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- January 2024
- 143 Pages
Global
From €3731EUR$4,250USD£3,246GBP
- Report
- June 2023
- 113 Pages
Global
From €3906EUR$4,450USD£3,398GBP
- Report
- December 2022
- 142 Pages
Global
From €3906EUR$4,450USD£3,398GBP
- Report
- August 2022
- 140 Pages
Global
From €3731EUR$4,250USD£3,246GBP
- Report
- December 2025
- 150 Pages
Germany
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- November 2025
- 150 Pages
India
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- November 2025
- 150 Pages
Japan
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- December 2024
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- November 2024
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- November 2024
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- August 2024
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- January 2024
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more